Cosmos Health Inc. financial data

Symbol
COSM on Nasdaq
Industry
Wholesale-Drugs, Proprietaries & Druggists' Sundries
Location
5 Agiou Georgiou, Pilea, Thessaloniki, Greece
State of incorporation
NV
Fiscal year end
December 31
Former names
Cosmos Holdings Inc. (to 12/19/2022), PRIME ESTATES & DEVELOPMENTS INC (to 1/3/2014)
Latest financial report
10-Q - Q3 2024 - Nov 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 144 % -39.7%
Quick Ratio 19.3 % -13.5%
Debt-to-equity 84.3 % +39.3%
Return On Equity -59.2 % -62.4%
Return On Assets -32.2 % -42.2%
Operating Margin -36 % -14.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 17.8M shares
Common Stock, Shares, Outstanding 23.3M shares +79.2%
Entity Public Float 28.8M USD +378%
Common Stock, Value, Issued 23.3K USD +78.6%
Weighted Average Number of Shares Outstanding, Basic 18.4M shares +46.3%
Weighted Average Number of Shares Outstanding, Diluted 18.4M shares +46.3%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 56M USD +13%
Selling and Marketing Expense 588K USD -45.4%
General and Administrative Expense 17.6M USD +28.7%
Operating Income (Loss) -20.2M USD -29.7%
Nonoperating Income (Expense) -228K USD -197%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -20.4M USD -33.2%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -20.4M USD -30.6%
Earnings Per Share, Basic -2.46 USD/shares -66.7%
Earnings Per Share, Diluted -2.46 USD/shares -515%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 2.23M USD +297%
Marketable Securities, Current 22.8K USD +30.1%
Accounts Receivable, after Allowance for Credit Loss, Current 17.5M USD -31.7%
Inventory, Net 4.89M USD -18%
Assets, Current 36.2M USD -22%
Property, Plant and Equipment, Net 10.6M USD +3.18%
Operating Lease, Right-of-Use Asset 711K USD -10.9%
Intangible Assets, Net (Excluding Goodwill) 7.7M USD +91.7%
Goodwill 49.7K USD 0%
Assets 64.5M USD -9.79%
Accrued Liabilities, Current 186K USD +125%
Liabilities, Current 25.2M USD +11.6%
Operating Lease, Liability, Noncurrent 468K USD -25.5%
Other Liabilities, Noncurrent 1.21M USD +277%
Liabilities 29.5M USD +9.59%
Accumulated Other Comprehensive Income (Loss), Net of Tax -448K USD +72.1%
Retained Earnings (Accumulated Deficit) -104M USD -47.1%
Stockholders' Equity Attributable to Parent 35M USD -20.9%
Liabilities and Equity 64.5M USD -9.79%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.41M USD +46.2%
Net Cash Provided by (Used in) Financing Activities 207K USD -90.8%
Net Cash Provided by (Used in) Investing Activities 126K USD
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 23.3M shares +78.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -2.97M USD +65.9%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3.31M USD +40.4%
Interest Paid, Excluding Capitalized Interest, Operating Activities 235K USD -60.1%
Depreciation 344K USD +151%
Payments to Acquire Property, Plant, and Equipment 82.7K USD +218%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -32.7M USD +22.1%
Property, Plant and Equipment, Gross 12M USD +7.29%
Operating Lease, Liability, Current 241K USD +42.4%
Deferred Income Tax Expense (Benefit) 398K USD -15.9%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 100M shares 0%
Operating Lease, Payments 41.1K USD +67.8%
Additional Paid in Capital 141M USD +19.5%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 522K USD +195%
Depreciation, Depletion and Amortization 312K USD +335%
Share-based Payment Arrangement, Expense 110K USD 0%
Interest Expense 1.03M USD -10.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%